Integrating Genomics Into Biobehavioral Research

Abstract

Biobehavioral research is becoming more established in nursing. This research paradigm includes a focus on the interactions of biological and behavioral variables and their impact on health outcomes. Nurse researchers have incorporated genomics as a research focus. However, biobehavioral and genomic approaches have often been viewed as separate paradigms. This article provides research exemplars from the liver transplantation population to illustrate how genomics can be integrated into a biobehavioral model of nursing research. Examples of how this integrated approach may be utilized to address gaps of knowledge are provided.

Keywords

biobehavioral research transplantation genetics/genomics liver transplantation biobehavioral transplantation model

Get full access to this article

View all access options for this article.

References

Ader

(2007). Psychoneuroimmunology 4th ed. Amsterdam, Netherlands: Elsevier/Academic Press.

Barginear

M. F.

Bradley

Shapira

Budman

D. R.

(2008). Implications of applied research for prognosis and therapy of breast cancer. Critical Reviews in Oncology and Hematology, 65, 223–234.

Bathgate

A. J.

Pravica

Perrey

Therapondos

Plevris

J. N.

Hayes

P. C.

Hutchinson

I. V.

(2000). The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation, 69, 1514–1517.

Brouard

Ashton-Chess

Soulillou

J. P.

(2008). Surrogate markers for the prediction of long-term outcome in transplantation: Nantes Actualite Transplantation (NAT) 2007 meeting report. Human Immunology, 69, 2–8.

Charlton

(2009). Obesity, hyperlipidemia, and metabolic syndrome. Liver Transplantation, 15, S83–S89.

Chu

Q. D.

Holm

Byrnes

B. D.

(2008). Translational research in breast cancer. Surgical Oncology Clinics of North America, 17, 421–438, x.

Conley

Y. P.

Tinkle

M. B.

(2007). The future of genomic nursing research. Journal of Nursing Scholarship, 39, 17–24.

Dick

A. A.

Spitzer

A. L.

Seifert

C. F.

Deckert

Carithers

R. L.

Jr. Reyes

J. D.

Perkins

J. D.

(2009). Liver transplantation at the extremes of the body mass index. Liver Transplantation, 15, 968–977.

Drent

Moons

De Geest

Kleibeuker

J. H.

Haagsma

E. B.

(2008). Symptom experience associated with immunosuppressive drugs after liver transplantation in adults: Possible relationship with medication non-compliance? Clinical Transplantation, 22, 700–709.

10.

Driscoll

(2007). Risk factors for posttransplant diabetes mellitus: A review of the literature. Progress in Transplantation, 17, 295–301.

11.

Driscoll

C. J.

Cashion

A. K.

Hathaway

D. K.

Thompson

Conley

Riely

Homayouni

(2006). Blood gene expression profiling in liver transplant recipients with hepatitis C and post transplant diabetes mellitus. Transplantation Proceedings, 38, 3646–3648. doi:10.1016/j.transproceed.2006.10.116.

12.

Fernandes

Koneru

Fernandes

Hameed

Cohen

M. C.

Raveche

Cohen

(2002). Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients. Transplantation, 73, 1886–1891.

13.

Fukudo

Yano

Yoshimura

Masuda

Uesugi

Hosohata

Inui

(2008). Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients. Pharmacogenetics and Genomics, 18, 413–423.

14.

Goddard

Williams

Morland

Qin

Gladue

Hubscher

S. G.

Adams

D. H.

(2001). Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. Transplantation, 72, 1957–1967.

15.

Guckelberger

(2009). Long-term medical comorbidities and their management: Hypertension/cardiovascular disease. Liver Transplantation, 15, S75–S78.

16.

Ioannou

G. N.

Perkins

J. D.

Carithers

R. L.

Jr. (2008). Liver transplantation for hepatocellular carcinoma: Impact of the MELD allocation system and predictors of survival. Gastroenterology, 134, 1342–1351.

17.

Kraemer

H. C.

Stice

Kazdin

Offord

Kupfer

(2001). How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. American Journal of Psychiatry, 158, 848–856.

18.

Krasnoff

J. B.

Vintro

A. Q.

Ascher

N. L.

Bass

N. M.

Paul

S. M.

Dodd

M. J.

Painter

P. L.

(2006). A randomized trial of exercise and dietary counseling after liver transplantation. American Journal of Transplantation, 6, 1896–1905.

19.

Marder

B. A.

Schroppel

Lin

Schiano

Parekh

Tomer

Murphy

(2003). The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation. American Journal of Transplantation, 3, 424–431.

20.

Mas

V. R.

Maluf

D. G.

Archer

K. J.

Yanek

Bornstein

Fisher

R. A.

(2009). Proteomic analysis of HCV cirrhosis and HCV-induced HCC: Identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation. Transplantation, 87, 143–152.

21.

McCain

N. L.

Gray

D. P.

Walter

J. M.

Robins

(2005). Implementing a comprehensive approach to the study of health dynamics using the psychoneuroimmunology paradigm. ANS. Advances in Nursing Science, 28, 320–332.

22.

Mells

Neuberger

(2009). Long-term care of the liver allograft recipient. Seminars in Liver Disease, 29, 102–120.

23.

O’Carroll

R. E.

McGregor

L. M.

Swanson

Masterton

Hayes

P. C.

(2006). Adherence to medication after liver transplantation in Scotland: A pilot study. Liver Transplantation, 12, 1862–1868.

24.

Pinsky

B. W.

Takemoto

S. K.

Lentine

K. L.

Burroughs

T. E.

Schnitzler

M. A.

Salvalaggio

P. R.

(2009). Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. American Journal of Transplantation, 9, 2597–2606.

25.

Scherer

M. N.

Banas

Mantouvalou

Schnitzbauer

Obed

Kramer

B. K.

Schlitt

H. J.

(2007). Current concepts and perspectives of immunosuppression in organ transplantation. Langenbecks Archives of Surgery, 392, 511–523.

26.

Schröppel

Fischereder

Ashkar

Lin

Krämer

B. K.

Mardera

Murphy

(2002). The impact of polymorphisms in chemokine and chemokine receptors on outcomes in liver transplantation. American Journal of Transplantation, 2, 640–645.

27.

Sethi

Stravitz

R. T.

(2007). Review article: Medical management of the liver transplant recipient—A primer for non-transplant doctors. Alimentary Pharmacology and Therapeutics, 25, 229–245.

28.

Smith

H. E.

Jones

J. P.

Kalhorn

T. F.

III Farin

F. M.

Stapleton

P. L.

Davis

C. L.

Totah

R. A.

(2008). Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease. Pharmacogenetics and Genomics, 18, 943–953.

29.

van der Heide

Dijkstra

Porte

R. J.

Kleibeuker

J. H.

Haagsma

E. B.

(2009). Smoking behavior in liver transplant recipients. Liver Transplantation, 15, 648–655.